The Nine-Year Sustained Cost-Containment Impact of Swiss Pilot Physicians-Pharmacists Quality Circles

Abstract

The PPQC work process has yielded sustainable results, such as significant cost savings, higher penetration of generics and reflection on patient safety, and the place of "new" drugs in therapy. The PPQCs may also constitute a solid basis for implementing more comprehensive collaborative programs, such as medication reviews, adherence-enhancing interventions, or disease management approaches.

Impacto de intervenções para promoção do uso de medicamentos genéricos: revisão sistemática

“…All used secondary data from prescription records and drug sales. A study was conducted in a high-middle-income country 16 and 16 in high-income countries 3,17,25,26,[30][31][32][35][36][37][38][39][40][41][42] . The selected designs were two RCTs, five NRCTs, seven CBAs and three ITS.…”

“…The selected designs were two RCTs, five NRCTs, seven CBAs and three ITS. The interventions were found to be educational 3,[16][17][18]25,26,[30][31][32]35 , of financial incentive 4,32,36,37 , electronic prescription 38,39 and managerial 40 . The main characteristics of the studies are summarized in Chart 1.…”

“…Intervention affecting the prescriber's behavior Among educational interventions, most aimed at changing the prescriber's behavior in relation to increased prescription of generic drugs 3,17,18,25,26,[31][32] or reduced prescription by the reference name 16 . These interventions showed small to average increase in generic prescription and average reduction in the prescription by the reference name, but the quality of evidence of these studies was very low (Chart 3).…”

“…Niquille et al 25 , Wensing et al 30 , Rausell Rausell et al 17 , Calvo Alcántara et al 3 Rausell Rausell et al 17 evaluated the effect of personalized monthly reports containing pre- Moderate Small increase It is likely that the educational intervention has affected the pharmacist, but this effect has been minimal.…”

“…These studies 3,[16][17][18]25,26,[30][31][32] showed small to medium impact, always favorable to generic prescription, but with very low quality evidence (Chartes 2 and 3).…”